ロード中...
(123)I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations
Reduced uptake of (123)I- metaiodobenzylguanidine (MIBG) on cardiac gammagraphy and impaired odor identification are markers of neurodegenerative diseases with Lewy bodies (LB) as a pathological hallmark, such as idiopathic Parkinson’s disease (IPD). LRRK2 patients present with a clinical syndrome i...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer-Verlag
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3101340/ https://ncbi.nlm.nih.gov/pubmed/21221623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-010-5896-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|